This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Harvest Technologies Corporation Files Amended Patent Infringement Complaint Against ThermoGenesis Corporation And Celling Technologies LLC

PLYMOUTH, Mass., Feb. 20, 2013 /PRNewswire/ --  Harvest Technologies Corporation (Harvest) announced that it filed an amended patent infringement complaint on February 15, 2013 in the US District Court of Delaware against ThermoGenesis Corporation (ThermoGenesis) and Celling Technologies LLC.  The complaint was amended to include Celling Technologies and alleges that the ThermoGenesis' Res-Q™ 60 BMC system, also sold by Celling Technologies as the ART 21 ® BMC System, infringes two patents for which Harvest Technology owns the rights.  These patents relate to Harvest's proprietary floating shelf technology that has been shown in studies to provide superior cellular concentration.  The complaint also requests an injunction against further sales of the product in the U.S.

"Harvest Technologies has invested many years and millions of dollars in development of its cellular therapy products," said Gael Tisack, Vice President of Intellectual Property for Terumo Americas Holding.  "We will continue to take all steps necessary to ensure that we protect our intellectual property and enforce our patent rights."

Harvest Technologies is the leading cellular therapy global manufacturer that has developed       point-of-care products to process and concentrate multiple biologics.  These include high-density platelet rich plasma (APC + ®), bone marrow aspirate concentrate (BMAC ®) and adipose tissue.  The company is headquartered in Plymouth, Massachusetts.  It is one of several subsidiaries of Terumo Corporation of Japan that is focused in cellular therapies and biologics.  For more information, visit www.harvesttech.com or call 508-732-7500.

Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with    $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures, and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use.

Harvest is a registered trademark of Harvest Technologies Corporation.  Terumo ® is a registered trademark of Terumo Corporation. Res-Q is a trademark of ThermoGenesis Corporation.  Celling Technologies ® is a registered trademark of Celling Technologies LLC.  ART 21 is a trademark of Celling Technologies ®

SOURCE Harvest Technologies Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 +1.21 0.06%
NASDAQ 4,828.3250 +15.6170 0.32%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs